Abstract: An elastic articulation comprising a first sleeve and a second sleeve is provided. The first sleeve and the second sleeve each include a respective outer armature, a respective inner armature, and a respective elastic body between their respective outer and inner armatures. The elastic articulation also comprises a ring longitudinally connecting the first sleeve and the second sleeve. The ring forms a radial stop between the inner armature and the outer armature of the first sleeve, and between the inner armature and the outer armature of the second sleeve. The elastic articulation improves damping control in different directions.

Abstract: An elastic articulation comprising a first sleeve and a second sleeve is provided. The first sleeve and the second sleeve each include a respective outer armature, a respective inner armature, and a respective elastic body between their respective outer and inner armatures. The elastic articulation also comprises a ring longitudinally connecting the first sleeve and the second sleeve. The ring forms a radial stop between the inner armature and the outer armature of the first sleeve, and between the inner armature and the outer armature of the second sleeve. The elastic articulation improves damping control in different directions.

Abstract: The present invention encompasses a vaccine composition and method of use for treating heartworm infestation in mammals. The vaccine composition includes chimeric antigens engineered and manufactured using the genetic code (i.e., the amino acid or protein sequence) of the target sequence. After introduction of the vaccine composition containing the target antigen into the host (e.g., a canine), the host will generate antibodies as part of its robust immune response to the antigen. As the antibodies circulate through the host's plasma, heartworm larvae will consume the antibodies as they feed on the plasma. The antibodies will then act on internal targets of the worm recognized as antigens.